Sera Prognostics

Category Archives

Agilent Technologies and Sera Prognostics Enter Strategic

SANTA CLARA, Calif., and SALT LAKE CITY, Utah, Feb. 12, 2013 – Agilent Technologies Inc. (NYSE: A) and Sera Prognostics Inc., a women’s health company, Read more...

Sera Prognostics Appoints Ilia Ichetovkin, Ph.D. as VP of Laboratory Operations

Experienced Diagnostics Operations Executive Joins Sera Team SALT LAKE CITY, UTAH (October 3, 2012) – Sera Prognostics, Inc., a women’s health company Read more...

Sera Prognostics, Inc. Appoints Sherree Frazier as Vice President of Sales and Marketing

Experienced Women’s Healthcare Executive joins Sera team SALT LAKE CITY, UTAH (July 2,2012)– Sera Prognostics, Inc., a women’s health company developing Read more...

Sera Prognostics Appoints Jay Boniface, Ph.D. Vice President of Research and Developement

SALT LAKE CITY, UT (January 9, 2012) -- Sera Prognostics, Inc., a women’s healthcompany developing diagnostic tests for early prediction of preterm birth Read more...

Sera Prognostics: Predicting preemies

BioCentury The Bernstein Report on BioBusiness Emerging Company Profile Sera Prognostics: Predicting preemies SERA PROGNOSTICS INC. Salt Lake City, Read more...

Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as CEO

Venture Firms InterWest Partners, Domain Associates and Catalyst Health Ventures Join Board of Directors SALT LAKE CITY, UT (November 15, 2011) -- Sera Read more...

Sera Prognostics’ Co-Founders Recognized for Groundbreaking Approach to Discovering Novel Biomarker Predictors for Preterm Birth

Sera Prognostics’ Co-Founders Recognized for Groundbreaking Approach to Discovering Novel Biomarker Predictors for Preterm Birth Research by M. Sean Read more...

Sera Prognostics Appoints Two Industry Veterans to Lead the Commercialization of its Preterm Birth Diagnostic Predictor

Sera Prognostics Appoints Two Industry Veterans to Lead the Commercialization of its Preterm Birth Diagnostic Predictor Former Myriad Genetic Labs President Read more...

Sera Prognostics Announces Positive Data from Second Study of Preterm Birth Test

Sera Prognostics Announces Positive Data from Second Study of Preterm Birth Test Researchers Report Results at the Society for Maternal-Fetal Medicine Read more...

Sera Prognostics Closes $1.4 million Series A-1 Financing

Sera Prognostics Closes $1.4 million Series A-1 Financing SALT LAKE CITY, Jan. 4, 2011 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company Read more...

Page 3 of 3123

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184